BriefTea
Every story in sixty words
Get the free app no ads · no paywallNews · 1 April 2026
Unsplash / Diana Polekhina
The NHS will offer the weight-loss jab Wegovy, also known as semaglutide, free to 1.2 million eligible patients in England from this summer. It is approved for overweight people who have previously had a heart attack, stroke, or circulation problem. Clinical trials show the weekly injection cuts the risk of another major heart event by 20%.
Reported by BBC · How we write briefs
More briefs
TechnologyJapan Launches Mission to Bring Back Rock From Mars Moon Phobos General10 minutes free now in private car parks WorldRumours Claim Kim Jong-un Suffered Brain Haemorrhage TechnologyEx-OpenAI Engineer Accused of Bugging Had Saudi Backing, Prosecutors Say PoliticsEnergy Secretary Questioned Mahmood's Longer Wait for Migrant Settlement GeneralSam Fender Teases 2027 Stadium Tour Including Wembley Browse all stories →We would like to count visits and see which links bring readers here. That means storing a random ID in your browser. No cookies, no ads, no profile. How it works.